GlassScriptPhysician profile
Shaoleen Khaled Daly
NPI 1366063323
$636.50
in general payments reported to CMS, 2019-2025
17 companies · $481 in 2025
The $481 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $155 · 2025: $481.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $637.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $636.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $123.22 | 2024-2025 | Mounjaro, Zepbound |
| Novo Nordisk INC | $79.32 | 2025 | Ozempic, Wegovy, Rybelsus |
| Glaxosmithkline, LLC. | $70.65 | 2025 | Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $41.93 | 2024-2025 | Airsupra |
| Shield Therapeutics INC | $40.83 | 2024-2025 | |
| Cranial Technologies, INC | $35.01 | 2025 | Doc Band |
| Abbvie INC. | $32.23 | 2024-2025 | |
| Organon LLC | $27.88 | 2024-2025 | Nexplanon |
| Daiichi Sankyo INC. | $27.28 | 2025 | Injectafer |
| Zimmer Biomet Holdings, INC. | $26.66 | 2025 | Persona |
| Alk-Abello, INC | $24.67 | 2025 | Neffy |
| Hologic Sales and Service, LLC | $22.87 | 2025 | Aptima, Thinprep 2000 Processor |
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.01 | 2024 | Jardiance |
| Amgen INC. | $17.65 | 2025 | Krystexxa |
| Bayer Healthcare Pharmaceuticals INC. | $15.67 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tolmar, INC. | $15.16 | 2024 | |
| Exact Sciences Corporation | $14.46 | 2025 | The Cologuard Plus Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shaoleen Daly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.